Completed
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
NCT04945772
- Conditions
- Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +14 more
- Locations
-
- Nanoscope Clinical Site Beverly Hills, California, United States
- Nanoscope Clinical Site Pensacola, Florida, United States
- Nanoscope Clinical Site Fargo, North Dakota, United States
- Nanoscope Clinical Site Houston, Texas, United States